| Glendale Pharmacy Llc | |
| 12444 Warwick Blvd, Newport News, Virginia 23606 | |
| (757) 595-3355 |
| Name | Glendale Pharmacy Llc |
|---|---|
| Organization Name | Glendale Pharmacy, Llc |
| Location | 12444 Warwick Blvd, Newport News, Virginia 23606 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (757) 595-3355 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
CEA-Leti today announced that after extensive beta testing at five French research facilities, its new imaging system for near-infrared fluorescence-enhanced diffuse optical tomography (fDOT) is ready for commercial applications.
Testing for breast cancer risk was the subject of remarks by two featured speakers at a recent congressional reception on Capitol Hill. The event generated momentum to pass the EARLY Act and raise awareness about breast cancer in young adult women.
Recognizing that robust statistical tools are essential for ensuring accurate results for increasingly advanced medical tests, Clinical and Laboratory Standards Institute (CLSI) and Analyse-it Software, Ltd. (Analyse-it®), are pleased to announce a new joint venture partnership to combine CLSI's expertise in developing best practice standards and guidelines for the medical laboratory with the power of Analyse-it's expertise in developing statistical software.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
| NPI Number | 1669642922 |
| Organization Name | GLENDALE PHARMACY, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 12444 Warwick Blvd, Newport News, VA 23606 |
| Phone Number | 757-595-3355 |
News Archive
CEA-Leti today announced that after extensive beta testing at five French research facilities, its new imaging system for near-infrared fluorescence-enhanced diffuse optical tomography (fDOT) is ready for commercial applications.
Testing for breast cancer risk was the subject of remarks by two featured speakers at a recent congressional reception on Capitol Hill. The event generated momentum to pass the EARLY Act and raise awareness about breast cancer in young adult women.
Recognizing that robust statistical tools are essential for ensuring accurate results for increasingly advanced medical tests, Clinical and Laboratory Standards Institute (CLSI) and Analyse-it Software, Ltd. (Analyse-it®), are pleased to announce a new joint venture partnership to combine CLSI's expertise in developing best practice standards and guidelines for the medical laboratory with the power of Analyse-it's expertise in developing statistical software.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
| NPI Number | 1811646805 |
| Organization Name | GLENDALE PHARMACY, LLC |
| Type | Long Term Care Pharmacy |
| Address | 12444 Warwick Blvd, Newport News, VA 23606 |
| Phone Number | 757-595-3355 |
News Archive
CEA-Leti today announced that after extensive beta testing at five French research facilities, its new imaging system for near-infrared fluorescence-enhanced diffuse optical tomography (fDOT) is ready for commercial applications.
Testing for breast cancer risk was the subject of remarks by two featured speakers at a recent congressional reception on Capitol Hill. The event generated momentum to pass the EARLY Act and raise awareness about breast cancer in young adult women.
Recognizing that robust statistical tools are essential for ensuring accurate results for increasingly advanced medical tests, Clinical and Laboratory Standards Institute (CLSI) and Analyse-it Software, Ltd. (Analyse-it®), are pleased to announce a new joint venture partnership to combine CLSI's expertise in developing best practice standards and guidelines for the medical laboratory with the power of Analyse-it's expertise in developing statistical software.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
News Archive
CEA-Leti today announced that after extensive beta testing at five French research facilities, its new imaging system for near-infrared fluorescence-enhanced diffuse optical tomography (fDOT) is ready for commercial applications.
Testing for breast cancer risk was the subject of remarks by two featured speakers at a recent congressional reception on Capitol Hill. The event generated momentum to pass the EARLY Act and raise awareness about breast cancer in young adult women.
Recognizing that robust statistical tools are essential for ensuring accurate results for increasingly advanced medical tests, Clinical and Laboratory Standards Institute (CLSI) and Analyse-it Software, Ltd. (Analyse-it®), are pleased to announce a new joint venture partnership to combine CLSI's expertise in developing best practice standards and guidelines for the medical laboratory with the power of Analyse-it's expertise in developing statistical software.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
1st Choice In-homecare Inc Type: Medicare Supplier Location: 321 Ed Wright Right Lane Suite B-c, Newport News, Virginia 23606 Phone: (757) 496-2030 | |
Med Emporium #2 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 629 Pilot House Dr, Newport News, Virginia 23606 Phone: (757) 434-5777 | |
Care Plus Cvs/pharmacy #10922 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4500 Washington Ave, Newport News, Virginia 23607 Phone: (757) 928-0860 | |
Coastal Prosthetics And Orthotics L Type: Prosthetic/Orthotic Supplier Location: 11818 Rock Landing Dr, Newport News, Virginia 23606 Phone: (757) 240-4228 | |
Rite Aid Pharmacy 11285 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 13271 Warwick Blvd, Newport News, Virginia 23602 Phone: (757) 874-3047 |